• Home
    • Company
    • Privacy Policy
    • Terms of Use
    • Quality Assurance & Standards/ISO
  • ARC's Solution
  • Products
    • Endoscope Cleaning Station (ECS1)
    • Automated Endoscope Reprocessor (PT3 AER)
    • Endoscope Drying & Storage Cabinet (EC10H)
    • Endoscope Storage Cabinet (HDE20)
  • Distributors
  • Resources
    • Canadian Society of Gastroenterology Nurses & Associates
    • Society of Gastroenterology Nurses and Associates
    • Joint Advisory Group
  • Blog
  • Contact Us
  • Login
  • Français
ARC Healthcare Solutions

Stopping the Superbug.

2/24/2015

0 Comments

 
Reports of yet another CRE outbreak have surfaced, this time in North Carolina leaving two patients dead and 16 hospitalized. Once again, these infections can be traced back to contaminated duodenoscopes that were not sufficiently cleaned and disinfected. Because of the complex nature of the elevator mechanism on the tip of the endoscope, it makes it nearly impossible to complete one of the crucial steps in the manual cleaning process; brushing. 

At this time, CRE infections have been reported in almost every American state causing hospitals and clinics to frantically look for ways to prevent the spread of the superbug going forward. The FDA has now released a statement regarding the recent CRE outbreaks which includes recommendations for patients and healthcare providers. Their statement includes steps that can be taken to promote awareness and understanding and provides instructions for reporting incidents, yet does not provide specific methods on how to ensure this bacteria is not transmitted going forward.

As a result, California lawmaker Ted Lieu has requested that congress investigate the issue which he says pose both health and national security risks. Lieu states that if the risk of this superbug is not mitigated, the human and societal costs will continue to rise. Additionally, healthcare facilities could face immense costs resulting from patient lawsuits. In spring 2013, Minnesota based UnitedHealth paid plaintiffs $24 million in compensatory damages and $366 million in punitive damages after referring the centre to patients after it was linked to a hepatitis C outbreak caused by unsafe injection practices. 

This latest outbreak stresses the importance of having the controls in place to ensure that endoscopes are reprocessed in a consistent manner that continually meets and exceeds the regulatory requirements. ARC's products offer results that exceed the current North American requirements and meet the guidelines established in the United Kingdom, which are more detailed and extensive. ARC is currently in the late stages of developing a feature for our ECS1 which supplements the manual cleaning process of duodenoscopes by using a high pressure port to flush the tiny elevator mechanism even if reprocessing staff cannot properly brush it. This high pressure technology is also used in our PT3AER to ensure that all parts of a duodenoscope come into contact with the disinfectant solution for the required length of time to kill remaining bacteria.
0 Comments



Leave a Reply.

    ARC Updates

    Read our latest company news, industry trends, product updates and upcoming events.

    Archives

    March 2016
    December 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    September 2014
    August 2014
    April 2014
    January 2014
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013

    Categories

    All
    Announcements
    Canada
    Industry Articles
    Pt3aer
    Uk
    Usa

    RSS Feed

Our Company.

About Us
Contact Us
Privacy Policy
Terms of Use

Our Quality.

Quality Assurance & Standards & ISO Certification

Our Products.

Endoscope Reprocessing
Endoscope Transport Cart
BSI Certification
Copyright © 2012 ARC Group of Companies Inc. | All Rights Reserved